Option Care Health (NASDAQ:OPCH) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen upgraded shares of Option Care Health (NASDAQ:OPCH) from a hold rating to a buy rating in a research report released on Saturday morning.

A number of other equities research analysts have also recently issued reports on OPCH. Barrington Research reduced their target price on shares of Option Care Health from $42.00 to $32.00 and set an “outperform” rating for the company in a research report on Friday, May 1st. Stephens reaffirmed an “equal weight” rating and set a $24.00 price target (down from $30.00) on shares of Option Care Health in a research report on Friday, July 17th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $24.00 price objective (down from $26.00) on shares of Option Care Health in a research note on Thursday. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price objective for the company. in a report on Friday, May 1st. Finally, TD Cowen decreased their target price on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a research report on Friday, May 1st. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Option Care Health presently has an average rating of “Hold” and a consensus target price of $29.92.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $23.03 on Friday. The firm has a market cap of $3.45 billion, a P/E ratio of 17.32, a price-to-earnings-growth ratio of 1.28 and a beta of 0.65. The company has a current ratio of 1.47, a quick ratio of 1.07 and a debt-to-equity ratio of 0.91. Option Care Health has a 1-year low of $18.01 and a 1-year high of $36.80. The business’s 50 day moving average is $21.49 and its 200-day moving average is $26.79.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. The business had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.42 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The firm’s quarterly revenue was up 1.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.41 EPS. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Equities research analysts predict that Option Care Health will post 1.64 earnings per share for the current year.

Insider Activity at Option Care Health

In other Option Care Health news, CEO John Charles Rademacher bought 12,500 shares of the firm’s stock in a transaction on Monday, May 4th. The shares were purchased at an average price of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the transaction, the chief executive officer directly owned 695,152 shares in the company, valued at approximately $14,723,319.36. The trade was a 1.83% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,610 shares of the firm’s stock in a transaction on Monday, May 4th. The stock was acquired at an average price of $21.41 per share, for a total transaction of $783,820.10. Following the transaction, the director owned 450,000 shares of the company’s stock, valued at approximately $9,634,500. The trade was a 8.86% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired 73,264 shares of company stock valued at $1,548,316 over the last ninety days. 1.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Option Care Health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Durable Capital Partners LP grew its position in Option Care Health by 134.2% during the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after acquiring an additional 4,720,988 shares during the last quarter. Southpoint Capital Advisors LP acquired a new position in Option Care Health in the 4th quarter worth about $95,580,000. Sumitomo Mitsui Trust Group Inc. bought a new position in Option Care Health in the first quarter valued at about $70,287,000. Norges Bank bought a new position in Option Care Health in the fourth quarter valued at about $61,787,000. Finally, Van Berkom & Associates Inc. acquired a new stake in shares of Option Care Health during the first quarter valued at about $42,739,000. 98.05% of the stock is owned by institutional investors.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.